Accessory mitral valve tissue

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:99061Q23.8
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Accessory mitral valve tissue (AMVT) is a rare congenital cardiac anomaly in which additional tissue, distinct from the normal mitral valve leaflets, is present in the left ventricular outflow tract (LVOT) or attached to the mitral valve apparatus. This accessory tissue may be a membrane, a fibrous strand, or a mobile mass that can cause obstruction of the LVOT, leading to subaortic stenosis. It is classified under congenital malformations of the mitral valve (ICD-10: Q23.8). AMVT may occur as an isolated finding or in association with other congenital heart defects such as ventricular septal defect, subaortic membrane, or other left-sided obstructive lesions. Clinically, many patients with accessory mitral valve tissue are asymptomatic and the condition is discovered incidentally during echocardiography performed for other reasons. When symptomatic, patients may present with exertional dyspnea, syncope, chest pain, or heart murmur due to LVOT obstruction. In some cases, the accessory tissue can also cause mitral regurgitation. The severity of symptoms depends on the degree of outflow tract obstruction and the mobility and size of the accessory tissue. Diagnosis is typically made by transthoracic or transesophageal echocardiography, which can delineate the morphology and hemodynamic significance of the accessory tissue. Treatment depends on the clinical significance of the anomaly. Asymptomatic patients with no significant LVOT obstruction may be managed conservatively with regular echocardiographic surveillance. Surgical excision of the accessory tissue is recommended for patients with significant LVOT obstruction (typically a mean gradient greater than 30-50 mmHg), progressive symptoms, or associated complications such as endocarditis or embolism. Surgical outcomes are generally favorable, with low recurrence rates, though long-term follow-up is recommended to monitor for recurrence of obstruction or development of mitral valve dysfunction.

Inheritance

Sporadic

Usually appears on its own, not inherited from a parent

Age of Onset

Variable

Can begin at different ages, from infancy through adulthood

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Accessory mitral valve tissue.

View clinical trials →

No actively recruiting trials found for Accessory mitral valve tissue at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Accessory mitral valve tissue community →

No specialists are currently listed for Accessory mitral valve tissue.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Accessory mitral valve tissue.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Accessory mitral valve tissueForum →

No community posts yet. Be the first to share your experience with Accessory mitral valve tissue.

Start the conversation →

Latest news about Accessory mitral valve tissue

No recent news articles for Accessory mitral valve tissue.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Accessory mitral valve tissue

What is Accessory mitral valve tissue?

Accessory mitral valve tissue (AMVT) is a rare congenital cardiac anomaly in which additional tissue, distinct from the normal mitral valve leaflets, is present in the left ventricular outflow tract (LVOT) or attached to the mitral valve apparatus. This accessory tissue may be a membrane, a fibrous strand, or a mobile mass that can cause obstruction of the LVOT, leading to subaortic stenosis. It is classified under congenital malformations of the mitral valve (ICD-10: Q23.8). AMVT may occur as an isolated finding or in association with other congenital heart defects such as ventricular septal

How is Accessory mitral valve tissue inherited?

Accessory mitral valve tissue follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.